Fact Check: Have Serum Institute, Bharat Biotech been rejected for emergency use of COVID vaccine?
Team Udayavani, Dec 10, 2020, 3:53 PM IST
Recently, a private news channel reported that the application for emergency use of the vaccine by Serum Institute and Bharat Biotech has been rejected by the DCGI.
“Both proposals are not approved due to inadequate safety and efficacy data available currently. Both have been asked for more data,” NDTV quoted sources as saying.
However, The Ministry of Health and Family Welfare (MoHFW) denied the claims made by NDTV as it dubbed the reports of Serum Institute of India and Bharat Biotech’s proposals getting rejected as false.
PIB tweeted saying, “Claim: NDTV has reported that the emergency use of the vaccine by Serum Institute and Bharat Biotech has been rejected. #PIBFactCheck: This claim is #Fake.”
Claim: NDTV has reported that the emergency use of the vaccine by Serum Institute and Bharat Biotech has been rejected#PIBFactCheck: This claim is #Fake. pic.twitter.com/zmUgqF2Nkt
— PIB Fact Check (@PIBFactCheck) December 9, 2020
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Key to past: Indore man collects 570 typewriters from across the world
Kambala: Tradition and modernity in coastal Karnataka
Dairy farmers in K’taka border areas selling milk to Kerala for higher price!
Kadaba: ‘Notion that only English-medium education leads to success is misleading’
Udupi: ‘Team Taulava’ takes charge to preserve endangered ancient monuments
MUST WATCH
Latest Additions
Air pollution: SC flags Delhi govt’s failure to implement GRAP-4 curbs on entry of trucks
Drugs worth Rs 6 crore seized in Bengaluru, five arrested
Siddaramaiah urges Nirmala Sitharaman to address NABARD’s loan cuts to farmers
Satwik-Chirag enter semifinals, Lakshya loses to Antonsen in China Masters
BJP stages protest against Congress govt in Karnataka over Waqf properties row
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.